Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program

BACKGROUND: Several antiplatelet medications used during and after percutaneous coronary intervention (PCI) are contraindicated for specific patient groups. A broad assessment of contraindicated medication use and associated clinical outcomes is not well described. METHODS AND RESULTS: Using nationa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Cardiovasc Qual Outcomes
Main Authors: Barnes, Geoffrey D., Stanislawski, Maggie A, Liu, Wenhui, Barón, Anna E, Armstrong, Ehrin J, Ho, P. Michael, Klein, Andrew, Maddox, Thomas M., Nallamothu, Brahmajee K., Rumsfeld, John S., Tsai, Thomas T., Bradley, Steven M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4956561/
https://ncbi.nlm.nih.gov/pubmed/27245070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.115.002043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados